Evidence map›Paper›PMID 26002285›Full record

ReviewSports medicine (Auckland, N.Z.)2015

Special Considerations in Medical Screening for Participants in Remote Endurance Events.

Jeremy Joslin, Martin D Hoffman, Ian Rogers, Robert M Worthing, Matt Ladbrook, Joshua Mularella

Abstract readReview
PubMed Publisher
In one paragraph

Review in Sports medicine (Auckland, N.Z.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Preventing Casualties in Ultramarathons.Sports medicine (Auckland, N.Z.) · 2021
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Jeremy JoslinDepartment of Emergency Medicine, State University of New York, Upstate Medical University, 550 East Genesee St., Syracuse, NY, 13210, USA, joslinj@upstate.edu.
Martin D Hoffman
Ian Rogers
Robert M Worthing
Matt Ladbrook
Joshua Mularella
SUNY Upstate Medical University · USUniversity of California Davis Medical Center · USUniversity of Kentucky · USUniversity of Notre Dame · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As participation at remote endurance events increases, so does the need to screen participants for potentially problematic medical conditions, but this process has been ill-defined to date. This article aims to outline a general approach to screening and discusses common or important medical conditions that may need consideration in the screening process. Medical conditions that are considered low risk may translate to high-risk conditions in the setting of a remote and austere location. Medical directors of remote endurance events should have a familiarity with assessing risks and applying informed consent principles to participation. While there are no specific standards on medical disqualification from an event based on medical history alone, several systematic considerations should be made that allow for an assessment of risk to an individual for a specific event. The medical director and event director, in discussion with the athlete and treating clinician when appropriate, should come to a consensus on participation when high-risk medical conditions become apparent during the screening process. Both modifications and accommodations to participation may be used to mitigate both clinical and medicolegal risk and allow for participation.

Indexed as

Physical EndurancePhysical ExaminationAcute Kidney InjuryAltitude SicknessAnaphylaxisCardiovascular DiseasesDiabetes MellitusGastrointestinal HemorrhageHeat StrokeHumansHypersensitivityHyponatremiaMass ScreeningMental DisordersRisk AssessmentSeizures

Identifiers

PMID26002285
OpenAlexW2180047141

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.